Dr. Howell et al., ANTI-HAV PREVALENCE IN A UK URBAN BLOOD-DONOR POPULATION AND THE EFFECT ON HUMAN NORMAL IG PROVISION, TRANSFUSION MEDICINE, 3(4), 1993, pp. 285-289
U.K. blood donors (873) were tested for anti-HAV and 21% were found to
be positive, with no obvious difference between the sexes. The positi
vity increased with age; 21% of donors between the ages of 30 and 50 y
ears were positive compared with 3% of donors less than 25 years of ag
e; in 1977, the rates were 47 and 10%, respectively. Older donors gene
rally had lower titres of anti-HAV which suggests that such donors wer
e infected at an early age. Subsequent improvements in hygiene may hav
e resulted in decreased anti-HAV prevalence in young people. Titres of
anti-HAV were determined for the four donors who gave a history of ja
undice and were seropositive: all four had high anti-HAV levels. Plasm
a from donors with a history of jaundice may therefore provide a cost-
effective source for enhancing the potency of human normal Ig.